Intrinsic Value

UroGen Pharma Ltd. (URGN)

$14.3

+0.04 (+0.28%)

Enterprise Value -54,078,874,343,891,120
Net Debt 4.39
Equity Value -54,078,874,343,891,128
Shares Outstanding 28.83
Equity Value Per Share -1,875,504,822,984,316.00



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt